Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

  • Caravaca-Fontan, Fernando|||0000-0002-5830-9663
  • Rivero, Marta
  • Cavero Escribano, Teresa|||0000-0001-5187-9906
  • Díaz Encarnación, Montserrat Mercedes|||0000-0001-5172-3370
  • Cabello, Virginia
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Quintana, Luis F.|||0000-0001-7582-8476
  • Marco Rusiñol, Helena|||0000-0002-7229-8729
  • Barros, Xoana|||0000-0001-9690-9769
  • Ramos Terrades, Natalia|||0000-0001-9832-326X
  • Rodríguez-Mendiola, Nuria
  • Cruz, Sonia
  • Fernández-Juárez, Gema|||0000-0001-6641-7763
  • Rodríguez Barba, Adela|||0000-0003-4382-3085
  • Pérez de José, Ana
  • Rabasco, Cristina
  • Rodado, Raquel
  • Fernández, Loreto
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
  • Ávila, Ana
  • Bravo, Luis
  • Espinosa, Natalia
  • Allende, Natalia|||0000-0001-9857-793X
  • Sánchez de la Nieta, María Dolores
  • Rodríguez García, Eva
  • Olea, Teresa
  • Melgosa, Marta|||0000-0001-6236-414X
  • Huerta, Ana|||0000-0003-3342-7628
  • Miquel, Rosa
  • Mon, Carmen
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • De Lorenzo, Alberto
  • Draibe, Juliana
  • González, Fayna
  • Shabaka, Amir|||0000-0001-7039-4701
  • López-Rubio, Maria Esperanza
  • Fenollosa, María Ángeles
  • Martín-Penagos, Luis
  • Da Silva, Iara
  • Alonso Titos, Juana
  • Rodríguez de Córdoba, Santiago|||0000-0001-6401-1874
  • Goicoechea de Jorge, Elena|||0000-0002-4978-2483
  • Praga, Manuel|||0000-0001-9270-1071
Background: C3 glomerulopathy is a rare and heterogeneous complement-driven disease. It is often challenging to accurately predict in clinical practice the individual kidney prognosis at baseline. We herein sought to develop and validate a prognostic nomogram to predict long-Term kidney survival. Methods: We conducted a retrospective, multicenter observational cohort study in 35 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases. The dataset was randomly divided into a training group (n = 87) and a validation group (n = 28). The least absolute shrinkage and selection operator (LASSO) regression was used to screen the main predictors of kidney outcome and to build the nomogram. The accuracy of the nomogram was assessed by discrimination and risk calibration in the training and validation sets. Results: The study group comprised 115 patients, of whom 46 (40%) reached kidney failure in a median follow-up of 49 months (range 24-112). No significant differences were observed in baseline estimated glomerular filtration rate (eGFR), proteinuria or total chronicity score of kidney biopsies, between patients in the training versus those in the validation set. The selected variables by LASSO were eGFR, proteinuria and total chronicity score. Based on a Cox model, a nomogram was developed for the prediction of kidney survival at 1, 2, 5 and 10 years from diagnosis. The C-index of the nomogram was 0.860 (95% confidence interval 0.834-0.887) and calibration plots showed optimal agreement between predicted and observed outcomes. Conclusions: We constructed and validated a practical nomogram with good discrimination and calibration to predict the risk of kidney failure in C3 glomerulopathy patients at 1, 2, 5 and 10 years.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

  • Caravaca-Fontan, Fernando|||0000-0002-5830-9663
  • Cavero Escribano, Teresa|||0000-0001-5187-9906
  • Díaz Encarnación, Montserrat Mercedes|||0000-0001-5172-3370
  • Cabello, Virginia
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Quintana, Luis F.|||0000-0001-7582-8476
  • Marco Rusiñol, Helena|||0000-0002-7229-8729
  • Barros, Xoana|||0000-0001-9690-9769
  • Ramos Terrades, Natalia|||0000-0001-9832-326X
  • Rodríguez-Mendiola, Nuria
  • Cruz, Sonia
  • Fernández-Juárez, Gema|||0000-0001-6641-7763
  • Rodríguez, Adela|||0000-0002-4899-6607
  • Pérez de José, Ana
  • Rabasco, Cristina
  • Rodado, Raquel
  • Fernández, Loreto
  • Pérez-Gómez, Vanessa
  • Ávila, Ana
  • Bravo, Luis
  • Espinosa, Natalia
  • Allende, Natalia|||0000-0001-9857-793X
  • Sánchez de la Nieta, María Dolores
  • Rodríguez García, Eva
  • Rivas, Begoña|||0000-0002-5886-9943
  • Melgosa, Marta|||0000-0001-6236-414X
  • Huerta, Ana|||0000-0003-3342-7628
  • Miquel, Rosa
  • Mon, Carmen
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • De Lorenzo, Alberto
  • Draibe, Juliana
  • González, Fayna
  • Shabaka, Amir|||0000-0001-7039-4701
  • López-Rubio, Maria Esperanza
  • Fenollosa, María Ángeles
  • Martín-Penagos, Luis
  • Da Silva, Iara
  • Titos, Juana Alonso
  • Rodríguez de Córdoba, Santiago|||0000-0001-6401-1874
  • Goicoechea de Jorge, Elena|||0000-0002-4978-2483
  • Praga, Manuel|||0000-0001-9270-1071
C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease. This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m 2, proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria. One hundred and fifteen patients with a median age of 30 years (interquartile range 19-50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d, both in those presenting with an eGFR under/above 30 ml/min per 1.73 m 2. The median eGFR slope of patients who reached kidney failure was -6.5 ml/min per 1.73 m 2 per year (interquartile range -1.6 to -17). Patients who showed a reduction in proteinuria over time did not reach kidney failure. On the basis of the rate of eGFR decline, patients were classified as faster eGFR decline (≥5 ml/min per 1.73 m 2 per year), slower (<5 ml/min per 1.73 m 2 per year), and those without decline. A faster eGFR decline was associated with higher probability of kidney failure. Kidney survival is significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d regardless of baseline eGFR, and a faster rate of decline in eGFR is associated with higher probability of kidney failure.